(Q43251148)

English

A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma

scientific article published on 30 October 2009

Statements

A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma (English)
Edo Vellenga
Sandra Croockewit
Marinus H van Oers
Peter von dem Borne
Pierre Wijermans
Ron Schaafsma
Okke de Weerdt
Shulamiet Wittebol
Michel Delforge
Henriëtte Berenschot
Gerard M Bos
Kon-Siong G Jie
Harm Sinnige
Marinus van Marwijk-Kooy
Peter Joosten
Rianne van Ammerlaan
Dutch-Belgian Hemato-Oncology Group (HOVON)
30 October 2009
1113-1120

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit